SCHEMBL9428841

SCHEMBL9428841

CC=CC(=O)N(c1ccc(-c2cccc(C)c2)s1)C1CCNC1

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 6/20 0.38
HSD17B2 P37059 6/20 0.38
NPC1 O15118 1/20 0.36
PKM P14618 1/20 0.36
RAB9A P51151 1/20 0.36
SLC6A2 P23975 7/20 0.36
SLC6A4 P31645 7/20 0.36
SLC6A3 Q01959 6/20 0.36
TACR1 P25103 2/20 0.35
TRPM8 Q7Z2W7 1/20 0.34
CHRM3 P20309 2/20 0.34
CYP2D6 P10635 2/20 0.33
KCNH2 Q12809 2/20 0.33
CNR1 P21554 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9429795 0.91 SLC6A4 (0.34) SLC6A2SLC6A4SLC6A3TACR1CHRM3
SCHEMBL9429798 0.90 CDK2AP1 (0.35) HSD17B1HSD17B2RAB9ASLC6A2SLC6A4
SCHEMBL9429101 0.89 CHRM1 (0.42) HSD17B1HSD17B2SLC6A2SLC6A4SLC6A3
SCHEMBL9429162 0.88 HDAC6 (0.41) HSD17B1HSD17B2SLC6A2SLC6A4SLC6A3
SCHEMBL9429149 0.87 SLC6A4 (0.36) SLC6A2SLC6A4SLC6A3TACR1CYP2D6
SCHEMBL9429749 0.85 EP300 (0.35) SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL9428532 0.85 MCHR1 (0.40) SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL9429984 0.85 SLC6A4 (0.39) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL9428834 0.84 SLC6A4 (0.39) SLC6A2SLC6A4SLC6A3TACR1CYP2D6
SCHEMBL9429644 0.83 APP (0.37) HSD17B1HSD17B2NPC1RAB9ATRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5328907-A Treatment of allograft rejection in mammals and antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1994-07-12 US disclosed
US-5108999-A For treating inflammation, autoimmune disease or allograft rejection in mammals SYNTEX (U.S.A.) INC. (US) 1992-04-28 US disclosed
EP-0440503-A1 4-Isoxazolecarboxamide derivatives SYNTEX (U.S.A.) INC. (US) 1991-08-07 EP disclosed
US-5001124-A 4-isoxazolecarboxamide derivatives SYNTEX (U.S.A.) INC. (US) 1991-03-19 US disclosed